TG Therapeutics TGTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $19.78M-14.2% | $23.04M-94.1% | $390.9M+1,287% | $28.19M+457% | $5.06M-78.3% | ||
| $32K+52.4% | $21K+23.5% | $17K+30.8% | $13K+62.5% | $8K-11.1% | ||
| $19.95M+27.5% | $15.65M-11.5% | $17.69M+8.1% | $16.36M+9.3% | $14.97M+25.3% | ||
| -$17.89M— | —— | -$23.15M— | —— | -$28.72M-12.0% | ||
| $51K-23.9% | $67K-16.3% | $80K+90.5% | $42K+68.0% | $25K+19.0% | ||
| -$9.86M— | —— | $46.36M+1,261% | -$3.99M+69.1% | -$12.93M— | ||
| $99.99M— | $0-100% | $78.24M+1,038% | $6.88M+12.3% | $6.12M-7.4% | ||
| $747.66M— | $0— | —— | —— | $0— | ||
| $390.83M— | $0+100% | -$78.24M-1,114% | -$6.44M-5.6% | -$6.1M— | ||
| $363.07M— | $0+100% | -$55.03M-1,735% | -$3M+93.7% | -$47.75M— | ||
| -$17.95M— | —— | -$23.23M— | —— | -$28.74M-12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does TG Therapeutics generate?
- TG Therapeutics (TGTX) generated -$95.4M in operating cash flow over the trailing twelve months.
- What is TG Therapeutics's free cash flow?
- After $240.0K of capital expenditures, TG Therapeutics's free cash flow was -$95.6M over the trailing twelve months, down 66.2% year over year.
- Where does TG Therapeutics's cash flow data come from?
- Every line is extracted from TG Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
